超声造影在大动脉巨细胞动脉炎中的应用:一项概念验证研究
活动性病变造影面积从32.2±16.8增至52.5±21.3 mm²(p<0.0001),非活动性病变保持不变。造影面积增加≥25%鉴别活动性与非活动性病变的敏感度和特异度分别为91.7%和100%。
要点
- 超声造影面积增加≥25%可高敏感度和特异度鉴别活动性大血管炎。
- 活动性大血管炎造影面积显著增加,非活动性病变则无变化。
- 超声造影可作为托珠单抗治疗时代监测疾病活动性的补充方法。
关键影像表现/征象
- 活动性大血管炎造影面积从32.2±16.8增至52.5±21.3 mm²(p<0.0001)。
- 非活动性大血管炎平均造影面积保持不变。
诊断标准与关键数值
- 造影面积增加≥25%鉴别活动性与非活动性大血管炎,敏感度91.7%,特异度100%。
临床应用与阅片要点
- 对疑似活动性大血管炎患者,可考虑超声造影观察造影面积动态变化。
- 注意在腔完全充盈时和其后4-8秒两次测量造影面积。
局限性
- 研究者未对临床数据设盲。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
C-Reactive protein and erythrocyte sedimentation rate are crucial parameters used to monitor giant cell arteritis (GCA). Given that tocilizumab is approved for the treatment of GCA, these parameters are less sensitive because of the effects of interleukin-6 receptor blockade. Thus, the optimal method for monitoring GCA patients undergoing tocilizumab therapy, especially patients exhibiting a persistent thickened vessel wall in large vessels, remains unclear. Contrast-enhanced ultrasonography (CEUS) can increase the visibility of tissue perfusion by slow blood flow, which cannot be detected by power color doppler. We used CEUS to investigate patients with active and inactive GCA of the large vessels (active large vessel arteritis [aLVV]/inactive large vessel arteritis [iLVV]) who were not administered tocilizumab in this proof-of-concept study. After injection of the ultrasound contrast agent, the contrasted area (CA) of large vessels in a transverse section was calculated twice: first when the lumen was contrasted completely and once again 4-8 s later. We investigated the value of increase in CA that exhibited the best sensitivity and specificity for aLVV. Twenty-four patients were included in this study: 15 with aLVV and 9 with iLVV. The CA increased from 32.2 ± 16.8 to 52.5 ± 21.3 mm2 (p < 0.0001) in aLVV. The mean CA remained unchanged in iLVV. The best cutoff value to differentiate between aLVV and iLVV was a ≥25% increase in CA with a sensitivity and specificity of 91.7% and 100%, respectively. Our study indicates that CEUS can detect aLVV with high sensitivity and specificity. Incorporation of CEUS into routine clinical practice might result in a good method for monitoring disease activity in LVV in GCA patients. The limitation of our study was the small number of patients and the lack of investigator blinding to clinical data.
引用
- Bergner R, Splitthoff J, Wadsack D, et al. Use of Contrast-Enhanced Ultrasound Sonography in Giant Cell Arteritis: A Proof-of-Concept Study. Ultrasound Med Biol. 2021. PMID: 34702639. doi:10.1016/j.ultrasmedbio.2021.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。